NEW YORK ( TheStreet) -- Onyx Pharmaceuticals (Nasdaq: ONXX) hit a new 52-week high Tuesday as it is currently trading at $133.40, above its previous 52-week high of $132.98 with 1.1 million shares traded as of 10:01 a.m. ET. Average volume has been 1.1 million shares over the past 30 days. Onyx has a market cap of $6.32 billion and is part of the health care sector and drugs industry. Shares are up 14.9% year to date as of the close of trading on Monday. Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.